Oragenics Inc. (OGEN)
AMEX: OGEN
· Real-Time Price · USD
0.19
-0.01 (-3.55%)
At close: May 02, 2025, 3:58 PM
0.18
-4.35%
After-hours: May 02, 2025, 05:30 PM EDT
-3.55% (1D)
| Bid | 0.17 |
| Market Cap | 4.11M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.57M |
| EPS (ttm) | -1.6 |
| PE Ratio (ttm) | -0.12 |
| Forward PE | -0.54 |
| Analyst | n/a |
| Ask | 0.2 |
| Volume | 214,316 |
| Avg. Volume (20D) | 4,875,464 |
| Open | 0.20 |
| Previous Close | 0.20 |
| Day's Range | 0.19 - 0.20 |
| 52-Week Range | 0.16 - 3.43 |
| Beta | 0.87 |
About OGEN
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 25, 2004
Employees 3
Stock Exchange AMEX
Ticker Symbol OGEN
Website https://www.oragenics.com
6 months ago
+6.39%
Oragenics shares are trading higher after the comp...
Unlock content with
Pro Subscription
8 months ago
-46.2%
Oragenics shares are trading lower after the company announced $4.45 million public offering of 8,106,584 shares at $0.55 per share.
